Vaccine Type: Replicating Viral Vector
This vaccine has reached Phase 2 trials.
About Trial Phases
There are no trials for this phase.
This vaccine is not yet approved.
Austria, Belgium, United States of America
Total Enrollment: 260
© 2021 McGill COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form